Guest Post by Prof. Contreras: Rambus Redux? – Standards, Patents and Non-Disclosure in the …
Guest post by Professor Jorge L. Contreras of the University of Utah School of Law. Note that the author was a partner at a law firm that was involved in …
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
Advanced intellectual property considerations: patent portfolio exploitation and joint development …
By Douglas L. Lineberry, shareholder, McNair Law Firm. Like the lucky dog that has finally managed to latch onto a car, patent owners sometimes face …
-
In: PATENT NEWS
Beyond the Merits: Generic Company Defense Strategies in Hatch-Waxman Litigation
In the context of litigation under the Hatch-Waxman Act, the wall of patent protection built by the brand does more than set out the metes-and-bounds …
-
In: PATENT NEWS
Hanging up: After 7 years, Apple and Samsung end smartphone patent wars
The smartphone patent wars are finally over. Apple and Samsung settled a seven-year legal fight on Wednesday, ending the most prominent case in a …
-
In: PATENT NEWS
No, Facebook did not patent secretly turning your phone mics on when it hears your TV
If you are not a patent lawyer in patent litigation and you are reading … This is so fundamental to reading patents that law students are taught “the …
-
In: PATENT NEWS
Supreme Court Hands Seismic Patent Owner a Win
From National Law Review. On June 22, 2018, the United States Supreme Court held that a patent owner can collect lost foreign profits for use of an …
-
In: PATENT NEWS
ITC Clears Arista In Ethernet Patent Dispute With Cisco
Law360 (June 28, 2018, 4:54 PM EDT) — The U.S. International Trade Commission has ruled in favor of Arista Networks Inc. in a case in which the …
-
In: PATENT NEWS
Chhabria Hits NPE and Its Law Firm With $222K Sanction for ‘Impossible’ Patent Claims
A San Francisco judge has sanctioned a Texas IP firm and its client $222,000 for pursuing a patent infringement suit against Fitbit Inc. based on what …
-
In: PATENT NEWS
Fed. Circ. Backs AstraZeneca, Impax Win In Zomig Patent Suit
Inc. that two AstraZeneca AB nasal spray patents covering Impax’s migraine drug Zomig are invalid, finding that it wasn’t obvious to make the drug into …
-
In: PATENT NEWS
biotechnology and software patent law a comparative review of new developments new directions …
comparative review of new developments new directions in patent law series PDF Full Ebook PDF File Size 10.68 MB in the past serve or fix your.